X @The Wall Street Journal
The Wall Street Journal·2025-12-22 07:44
Clinical Trial Outcome - The pharmaceutical company's ceralasertib combination failed to meet the primary endpoint in a late-stage clinical trial for advanced lung cancer [1]
Clinical Trial Outcome - The pharmaceutical company's ceralasertib combination failed to meet the primary endpoint in a late-stage clinical trial for advanced lung cancer [1]